Next-generation sequencing in diffuse large B-cell lymphoma highlights molecular divergence and therapeutic opportunities: a LYSA study S Dubois, PJ Viailly, S Mareschal, E Bohers, P Bertrand, P Ruminy, ... Clinical cancer research 22 (12), 2919-2928, 2016 | 240 | 2016 |
Molecular profile and FDG-PET/CT total metabolic tumor volume improve risk classification at diagnosis for patients with diffuse large B-cell lymphoma AS Cottereau, H Lanic, S Mareschal, M Meignan, P Vera, H Tilly, F Jardin, ... Clinical Cancer Research 22 (15), 3801-3809, 2016 | 181 | 2016 |
Sarcopenia is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy H Lanic, J Kraut-Tauzia, R Modzelewski, F Clatot, S Mareschal, ... Leukemia & lymphoma 55 (4), 817-823, 2014 | 149 | 2014 |
The isotype of the BCR as a surrogate for the GCB and ABC molecular subtypes in diffuse large B-cell lymphoma P Ruminy, P Etancelin, L Couronné, F Parmentier, V Rainville, ... Leukemia 25 (4), 681-688, 2011 | 134 | 2011 |
Identification of somatic mutations in primary cutaneous diffuse large B-cell lymphoma, leg type by massive parallel sequencing S Mareschal, A Pham-Ledard, PJ Viailly, S Dubois, P Bertrand, ... Journal of Investigative Dermatology 137 (9), 1984-1994, 2017 | 119 | 2017 |
Detection and prognostic value of recurrent exportin 1 mutations in tumor and cell-free circulating DNA of patients with classical Hodgkin lymphoma V Camus, A Stamatoullas, S Mareschal, PJ Viailly, N Sarafan-Vasseur, ... Haematologica 101 (9), 1094, 2016 | 117 | 2016 |
The proportion of activated B-cell like subtype among de novo diffuse large B-cell lymphoma increases with age S Mareschal, H Lanic, P Ruminy, C Bastard, H Tilly, F Jardin Haematologica 96 (12), 1888, 2011 | 115 | 2011 |
Biological and clinical relevance of associated genomic alterations in MYD88 L265P and non-L265P–mutated diffuse large B-cell lymphoma: analysis of 361 cases S Dubois, PJ Viailly, E Bohers, P Bertrand, P Ruminy, V Marchand, ... Clinical Cancer Research 23 (9), 2232-2244, 2017 | 112 | 2017 |
Targetable activating mutations are very frequent in GCB and ABC diffuse large B‐cell lymphoma E Bohers, S Mareschal, A Bouzelfen, V Marchand, P Ruminy, ... Genes, Chromosomes and Cancer 53 (2), 144-153, 2014 | 104 | 2014 |
Non-invasive detection of somatic mutations using next-generation sequencing in primary central nervous system lymphoma M Fontanilles, F Marguet, É Bohers, PJ Viailly, S Dubois, P Bertrand, ... Oncotarget 8 (29), 48157, 2017 | 103 | 2017 |
Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B‐cell lymphoma F Jardin, A Pujals, L Pelletier, E Bohers, V Camus, S Mareschal, S Dubois, ... American journal of hematology 91 (9), 923-930, 2016 | 102 | 2016 |
Whole exome sequencing of relapsed/refractory patients expands the repertoire of somatic mutations in diffuse large B‐cell lymphoma S Mareschal, S Dubois, PJ Viailly, P Bertrand, E Bohers, C Maingonnat, ... Genes, Chromosomes and Cancer 55 (3), 251-267, 2016 | 102 | 2016 |
EZH2 alterations in follicular lymphoma: biological and clinical correlations S Huet, L Xerri, B Tesson, S Mareschal, S Taix, L Mescam-Mancini, ... Blood cancer journal 7 (4), e555-e555, 2017 | 98 | 2017 |
Somatic mutations of cell-free circulating DNA detected by next-generation sequencing reflect the genetic changes in both germinal center B-cell-like and activated B-cell-like … E Bohers, PJ Viailly, S Dubois, P Bertrand, C Maingonnat, S Mareschal, ... Haematologica 100 (7), e280, 2015 | 94 | 2015 |
Digital PCR for quantification of recurrent and potentially actionable somatic mutations in circulating free DNA from patients with diffuse large B-cell lymphoma V Camus, N Sarafan-Vasseur, E Bohers, S Dubois, S Mareschal, ... Leukemia & lymphoma 57 (9), 2171-2179, 2016 | 93 | 2016 |
Outcome of patients older than 60 years with classical Hodgkin lymphoma treated with front line ABVD chemotherapy: frequent pulmonary events suggest limiting the use of … A Stamatoullas, P Brice, R Bouabdallah, S Mareschal, V Camus, I Rahal, ... British journal of haematology 170 (2), 179-184, 2015 | 84 | 2015 |
Accurate classification of germinal center B-cell–like/activated B-cell–like diffuse large B-cell lymphoma using a simple and rapid reverse transcriptase–multiplex ligation … S Mareschal, P Ruminy, C Bagacean, V Marchand, M Cornic, JP Jais, ... The Journal of Molecular Diagnostics 17 (3), 273-283, 2015 | 82 | 2015 |
Determination of molecular subtypes of diffuse large B-cell lymphoma using a reverse transcriptase multiplex ligation-dependent probe amplification classifier: a CALYM study V Bobée, P Ruminy, V Marchand, PJ Viailly, AA Sater, L Veresezan, ... The Journal of Molecular Diagnostics 19 (6), 892-904, 2017 | 56 | 2017 |
Interim positron emission tomography scan associated with international prognostic index and germinal center B cell-like signature as prognostic index in diffuse large B-cell … H Lanic, S Mareschal, F Mechken, JM Picquenot, M Cornic, C Maingonnat, ... Leukemia & lymphoma 53 (1), 34-42, 2012 | 55 | 2012 |
Immunoglobulin heavy chain/light chain pair measurement is associated with survival in diffuse large B-cell lymphoma F Jardin, MH Delfau-Larue, TJ Molina, C Copie-Bergman, J Brière, ... Leukemia & lymphoma 54 (9), 1898-1907, 2013 | 44 | 2013 |